BCR and chronic myelogenous leukemia, BCR-ABL1 positive: SPHK1 expression is up-regulated by the BCR/Abl translocation that is characteristic of chronic myeloid leukaemia [110], and signalling through the S1P2 receptor stabilises the oncogenic BCR/Abl fusion protein [102].